Correction: Zika Virus-Derived E-Diii Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies Without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

Vaccines - Switzerland
doi 10.3390/vaccines8010094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Author Correction: Human Antibodies to the Dengue Virus E-Dimer Epitope Have Therapeutic Activity Against Zika Virus Infection

Nature Immunology
AllergyImmunology
2020English

Cross-Reactive Dengue Virus-Derived Monoclonal Antibodies to Zika Virus Envelope Protein: Panacea or Pandora’s Box?

BMC Infectious Diseases
Infectious Diseases
2018English

On the Co-Infection of Dengue Fever and Zika Virus

Optimal Control Applications and Methods
ControlSystems EngineeringApplied MathematicsOptimizationSoftware
2019English

Development of Envelope Protein Antigens to Serologically Differentiate Zika From Dengue Virus Infection

Journal of Clinical Microbiology
Microbiology
2017English

Zika Virus Infection Elicits Auto-Antibodies to C1q

Scientific Reports
Multidisciplinary
2018English

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

Frontiers in Immunology
AllergyImmunology
2017English

Human Antibody Responses After Dengue Virus Infection Are Highly Cross-Reactive to Zika Virus

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

A New Class of Broadly Neutralizing Antibodies That Target the Glycan Loop of Zika Virus Envelope Protein

Cell Discovery
BiochemistryGeneticsCell BiologyMolecular Biology
2020English

Recombinant Lipidated Zika Virus Envelope Protein Domain III Elicits Durable Neutralizing Antibody Responses Against Zika Virus in Mice

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy